-transparent.png){kind=logo}
Treatment of rat allograft recipients before grafting with donor spleen cells and whole, pooled antidonor alloimmune serum results in indefinite renal allograft survival. The enhancement is immunologically specific. In these experiments a monoclonal, homogenous anti-BN antibody was produced by a hybridoma clone created by fusing the mouse-P3 myeloma with spleen cells from Lewis rats immunized with BN lymphoid cells. The hybridoma supernatent enhanced survival of LBN renal allografts in Lewis recipients as effectively as whole Lewis anti-BN antiserum. Dilution of the hybridoma supernatent by tenfold or a hundredfold abrogated the enhancement effect.
Related Publications
F P Stuart, and
T J McKearn, and
F W Fitch
November 1981,
Transplantation,
F P Stuart, and
T J McKearn, and
F W Fitch
March 1981,
Investigative urology,
F P Stuart, and
T J McKearn, and
F W Fitch
January 1988,
Current surgery,
F P Stuart, and
T J McKearn, and
F W Fitch
April 1973,
The British journal of surgery,
F P Stuart, and
T J McKearn, and
F W Fitch
January 1969,
Surgical forum,
F P Stuart, and
T J McKearn, and
F W Fitch
March 1972,
Transplantation,
F P Stuart, and
T J McKearn, and
F W Fitch
July 1968,
Surgery,
F P Stuart, and
T J McKearn, and
F W Fitch
October 1973,
Transplantation,
F P Stuart, and
T J McKearn, and
F W Fitch
November 1974,
Transplantation,
F P Stuart, and
T J McKearn, and
F W Fitch
January 1994,
Transplant international : official journal of the European Society for Organ Transplantation,
